Ireland - English - HPRA (Health Products Regulatory Authority)

wick pharma - zweigniederlassung der procter & gamble gmbh - phenylephrine hydrochloride; paracetamol - powder for oral solution - 1000/12.2 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Ireland - English - HPRA (Health Products Regulatory Authority)

procter & gamble (health & beauty care) limited - paracetamol, phenylephrine hydrochloride - powder for oral solution - 1000/12.2 milligram - analgesics and antipyretics

Ireland - English - HPRA (Health Products Regulatory Authority)

wick pharma - zweigniederlassung der procter & gamble gmbh - paracetamol; guaifenesin; phenylephrine hydrochloride - powder for oral solution - 500/200/10 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Ireland - English - HPRA (Health Products Regulatory Authority)

procter & gamble (health & beauty care) ltd - paracetamol; guaifenesin; phenylephrine hydrochloride - powder for oral solution - 500/200/10 milligram(s) - other cold preparations

United States - English - NLM (National Library of Medicine)

akorn - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride 25 mg in 1 ml - phenylephrine hydrochloride ophthalmic solution, usp 2.5% and 10%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)] . animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, caution should be exercised when phenylephrine hydrochloride ophthalmic solution 2.5% and 10% is administered to a nursing woman. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age [see contraindications (4.2) ]. no overall differences in safety and effectiveness have been observed between elderly and younger adult patients.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline consumer healthcare sdn. bhd. - paracetamol; phenylephrine hcl; chlorpheniramine maleate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline consumer healthcare sdn. bhd. - paracetamol; phenylephrine hcl -

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - phenylephrine hydrochloride, quantity: 0.1 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - phenylephrine hydrochloride is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia. it is also employed to overcome paroxysmal supraventricular tachycardia.

Namibia - English - Namibia Medicines Regulatory Council

adcock ingram ltd - paracetamol , ascorbic acid , caffeine , phenylephrine hcl , chlorpheniramine maleate - capsule - each capsule contains: paracetamol 300mg, ascorbic acid 75mg, caffeine 30mg, phenylephrine hcl 5mg, chlorpheniramine maleate 2mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline consumer healthcare sdn. bhd. - paracetamol; phenylephrine hcl -